Biomarkers are used to assess pathway-specific metabolites, such as those that represent disease activity. For example, lipidomic markers can indicate stages of NAFLD or NASH.
Biomarkers are used to assess pathway-specific metabolites, such as those that represent disease activity. For example, lipidomic markers can indicate stages of NAFLD or NASH.
